NAZ-2329

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameNAZ-2329
Drug Alias NameNAZ-2329NAZ2329
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-type tyrosine-protein phosphatase zeta inhibitorsReceptor-type tyrosine-protein phosphatase gamma inhibitors
TargetsReceptor-type tyrosine-protein phosphatase zetaReceptor-type tyrosine-protein phosphatase gamma
Therapy Area/IndicationsCarcinoma, Squamous CellGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAsubio Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAsubio Pharma Co LtdWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Squamous CellGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A